SCHEMBL4682121

SCHEMBL4682121

C=C(C)n1nc(-c2ccc(OC(F)(F)F)cc2)c(CC)c1C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM5A P29375 1/20 0.38
KDM2B Q8NHM5 1/20 0.38
KDM4C Q9H3R0 1/20 0.38
KDM5B Q9UGL1 1/20 0.38
PTGDR2 Q9Y5Y4 1/20 0.38
LIPE Q05469 2/20 0.38
BCHE P06276 1/20 0.38
ACHE P22303 1/20 0.38
MAPT P10636 2/20 0.37
TP53 P04637 2/20 0.37
AURKA O14965 1/20 0.37
TPX2 Q9ULW0 1/20 0.37
PTGER4 P35408 1/20 0.36
PTGES O14684 1/20 0.36
ERCC5 P28715 1/20 0.35
FEN1 P39748 1/20 0.35
ADORA3 P0DMS8 1/20 0.35
ELANE P08246 1/20 0.35
SUCNR1 Q9BXA5 1/20 0.35
GCGR P47871 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4682706 0.78 PTGER4 (0.48) PTGDR2TP53PTGER4PTGESGCGR
SCHEMBL4679883 0.78 PTGDR2 (0.40) KDM5AKDM2BKDM4CKDM5BPTGDR2
SCHEMBL4683639 0.71 GRK6 (0.45) KDM5AKDM2BKDM4CKDM5BMAPT
SCHEMBL4682118 0.69 MAPT (0.47) MAPTADORA3ELANE
SCHEMBL4685142 0.68 SCN9A (0.42) KDM2BKDM4CPTGDR2MAPT
SCHEMBL1686287 0.67 TRPV1 (0.48) AURKATPX2PTGER4AKR1C2AKR1C1
SCHEMBL4682043 0.66 PTGER4 (0.50) PTGDR2TP53PTGER4
SCHEMBL4685132 0.66 MAPT (0.42) KDM5AKDM2BKDM4CKDM5BLIPE
SCHEMBL5221151 0.66 MAPT (0.60) KDM5AKDM2BKDM4CKDM5BMAPT
SCHEMBL4681192 0.65 TRPM2 (0.41) KDM2BKDM4CPTGDR2PTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1513796-B1 PHENYLOXYALKANOIC ACID DERIVATIVES AS HPPAR ACTIVATORS SMITHKLINE BEECHAM CORP (US) 2008-02-13 EP disclosed
US-7241793-B2 Phenyloxyalkanonic acid derivatives as hPPAR activators SMITHKLINE BEECHAM CORPORATION (US) 2007-07-10 US disclosed
US-20050222424-A1 Phenyloxyalkanonic acid derivatives as hppar activators SMITHKLINE BEECHAM CORPORATION 2005-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222424-A1 Phenyloxyalkanonic acid derivatives as hppar activators CEL, HPN, LIPA KDM5A 2170/4885KDM2B 2898/4885KDM4C 3844/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.